Biotechnology Stocks II Performance Guide: C4 Therapeutics, Inc. (CCCC)
CCCC has no dividends.
Table and Chart of CCCC Performance
See what a $1,000 investment in CCCC is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CCCC Returns | |
|---|---|
| Start Date | Nov-30-2020 |
| Start Price | $34.20 |
| End Date | May-16-2024 |
| End Price | $5.97 |
| # Prices | 43 |
| Min Date | Oct-31-2023 |
| Min Price | $1.49 |
| Max Date | Sep-30-2021 |
| Max Price | $44.68 |
| Total Return | -82.54% |
| Annualized Return | -38.56% |
| Current Value of $1,000 Purchase | $175 |
| Number Returns | 903 |
| Average Return | -38.60% |
| Number Profitable Returns | 173 |
| Percent Profitable Returns | 19.16% |
| Number Unprofitable Returns | 730 |
| Percent Unprofitable Returns | 80.84% |
| Profitable to Unprofitable Returns Ratio | 0.24 |
| CCCC Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $410,771,000 |
| Beta | 3.186 | Price to Sales | 24.49 |
| Earnings per Share | $-2.6700 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.065 |
| PRICE DATA | |
| 52 Week High | $11.88 |
| 52 Week Low | $1.06 |
| Analyst Target Price | $18.75 |
| 50-Day Moving Average | $7.72 |
| 200-Day Moving Average | $4.826 |
| FINANCIAL DATA | |
| Revenue per Share | $0.418 |
| Revenue | $20,756,000 |
| Profit Margin | 0% |
| Return on Equity | -49.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CCCC Compare Returns with S&P 500
CCCC Trendline Chart
CCCC Moving Average Chart
CCCC Stock Return Map - See Patterns of Gains and Losses
CCCC Stock Returns/Purchase Dates